2013Journal of Capital Medical UniversityRequires access

Effect of oral estradiol valerate on the high sensitivity C-reactive protein in climacteric SD rats

Shu‐Li Yang

Open publisher page 0 citations

Abstract

Objective To investigate the effects of estrogen on the high sensitivity C-reactive protein(hs-CRP),IL-6.Methods Seventy SPF female SD rats,fifteen-month-old,were randomly divided into two groups by digital table method: treatment group and control group.The treatment group was given estradiol valerate orally,once per day,the control group was orally fed with physiological saline intragastric administration,once per day,fourteen weeks.After the treatment,blood samples were taken from the rats to assess the level of hs-CRP,IL-6.Results Fourteen weeks after intragastric administration,in the treatment group,serum hs-CRP level was lower than that in the control group(P 0.05);while the IL-6 level was lower than that in control group(P 0.05).Conclusion Intragastric administration of estradiol valerate might decrease the hs-CRP,so estradiol may play a positive protective role in cardiovascular disease prevention.

About this research paper

What this paper is about

Objective To investigate the effects of estrogen on the high sensitivity C-reactive protein(hs-CRP),IL-6.Methods Seventy SPF female SD rats,fifteen-month-old,were randomly divided into two groups by digital table method: treatment group and control group.The treatment group was given estradiol valerate orally,once per day,the control group was orally fed with physiological saline intragastric administration,once per day,fourteen weeks.After the treatment,blood samples were taken from the rats to assess the level of hs-CRP,IL-6.Results Fourteen weeks after intragastric administration,in the treatment group,serum hs-CRP level was lower than that in the control group(P 0.05);while the IL-6 level was lower than that in control group(P 0.05).Conclusion Intragastric administration of estradiol valerate might decrease the hs-CRP,so estradiol may play a positive protective role in cardiovascular disease prevention.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the effects of estrogen on the high sensitivity C-reactive protein(hs-CRP),IL-6.Methods Seventy SPF female SD rats,fifteen-month-old,were randomly divided into two groups by digital table method: treatment group and control group.The treatment group was given estradiol valerate orally,once per day,the control group was orally fed with physiological saline intragastric administration,once per day,fourteen weeks.After the treatment,blood samples were taken from the rats to assess the level of hs-CRP,IL-6.Results Fourteen weeks after intragastric administration,in the treatment group,serum hs-CRP level was lower than that in the control group(P 0.05);while the IL-6 level was lower than that in control group(P 0.05).Conclusion Intragastric administration of estradiol valerate might decrease the hs-CRP,so estradiol may play a positive protective role in cardiovascular disease prevention.

Key concepts: Estradiol valerate, Medicine, Estrogen, Climacteric, Internal medicine, C-reactive protein, Endocrinology, Valerate

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of oral estradiol valerate on the high sensitivity C-reactive protein in climacteric SD rats — Research Paper | ScholarLens